PH
Pharvaris N.V.
PHVS · NASDAQ
$37.74 -0.76% (-$0.29)
1M +8.61%
Market Cap 2.27B €
P/E Ratio -
Div. Yield -
ROE 61.24%
Bulios Fair Price
$25.94
31.3% downside
Trenutna cena
$37.74
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PHVS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
6 /100
Expensive P/B 7.56x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 22.04%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 61.56%
ROE 61.24%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 11.94x
Int. coverage -1,068.31x
Stability
62 /100
Moderate Beta -2.32x
EPS volatility 13.71%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PHVS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Berndt Modig
Employees
148
Headquarters
Zug
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report